Cross-cultural Adaptation of the 'Cold Intolerance Severity Score' (CISS) to the Dutch Language.
Ciss-DLV
Ciss-DLV-Cross-cultural Adaptation of the 'Cold Intolerance Severity Score' (CISS) to the Dutch Language.
1 other identifier
observational
100
1 country
1
Brief Summary
To report Cold intolerance by the CISS score in medicolegal patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedStudy Start
First participant enrolled
December 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedDecember 21, 2023
December 1, 2023
20 days
June 13, 2023
December 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of a Dutch language translation of standard cold intolerance form
Test and retest of a Dutch language model of the CISS score
1 year
Study Arms (2)
Handsurgery patients
patients recruited from trauma handsurgery outpatient clinic in an academic teaching hospital, level 1 trauma unit.
Medicolegal patients
Medicolegal patients that are examined in order to asses their personal injury claim.
Eligibility Criteria
Handsurgery patients and medicolegal patients
You may qualify if:
- \- Adult
- Traumatic hand injury
- Sufficient knowledge of the Dutch language (at least level B1)
You may not qualify if:
- \- Definitive total hand amputation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Handcentrum, Bilthoven, The Netherlandscollaborator
Study Sites (1)
Erasmuc MC
Rotterdam, South Holland, 3015 GD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reinier Feitz, MD PhD
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Reinier Feitz, MD, PhD, plastic surgeon
Study Record Dates
First Submitted
June 13, 2023
First Posted
June 29, 2023
Study Start
December 12, 2023
Primary Completion
January 1, 2024
Study Completion
January 1, 2025
Last Updated
December 21, 2023
Record last verified: 2023-12